Small Molecules

With US courts consistently ruling in favor of the PrEP drug manufacture, the CDC and DHHS have had no choice but to be humble.

The industry is under pressure to reduce the risks of nitrosamines in both in-development and on-market drug products.

The trends and challenges in oral solid dosage formulations contribute to greater stability for drugs used by patients worldwide.

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

An expert at Pierre Fabre Laboratories examines the landscape for innovation in cancer treatment.

From AI, to hot-melt extrusion, continuous processing, generics, and more – check out our free eBook.

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

How small molecule-focused CDMOs can help companies navigate the impact of the Inflation Reduction Act.

How to mitigate the risks involved in highly potent APIs.